Cargando…
Prenatal genetics in a post-Roe United States
The Supreme Court removed a federal right to abortion access in June 2022. This returned the legality of abortion to each of the 50 states. This will have a profound impact on the provision of prenatal care in general and prenatal genetic screening and testing.
Autores principales: | Allyse, Megan A., Michie, Marsha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381413/ https://www.ncbi.nlm.nih.gov/pubmed/35793676 http://dx.doi.org/10.1016/j.xcrm.2022.100690 |
Ejemplares similares
-
Gene modification therapies: Views of parents of people with Down syndrome
por: Michie, Marsha, et al.
Publicado: (2018) -
Missed period? The significance of period-tracking applications in a post-Roe America
por: Kelly, Bridget G., et al.
Publicado: (2023) -
Life without Roe v Wade
por: Ginsberg, Norman A., et al.
Publicado: (2021) -
Attitudes Towards Non-Invasive Prenatal Testing for Aneuploidy Among United States Adults of Reproductive Age
por: Allyse, Megan, et al.
Publicado: (2014) -
Never “totally prepared”: Support groups on helping families prepare for a child with a genetic condition
por: Craig, Kaitlynn P., et al.
Publicado: (2023)